Carregant...
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
BACKGROUND: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and costs associated with fluticasone propionate (an inhaled corticosteroid [ICS]) and salmeterol (a long-acting beta-agonist) in a single inhalation device (fluticasone propionate-salmeterol)...
Guardat en:
Autors principals: | , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Dove Medical Press
2012
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3536350/ https://ncbi.nlm.nih.gov/pubmed/23300347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S34582 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|